Skip to main content
Log in

Association of Cholesteryl Ester Transfer Protein (CETP) Gene -629C/A Polymorphism with Angiographically Proven Atherosclerosis

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Association of cholesteryl ester transfer protein (CETP) Gene -629C/A Polymorphism with angiographically proven atherosclerosis CETP gene has been linked to CAD risk via its role in HDL and LDL metabolism. There is no agreement of whether CETP is atherogenic or not. Furthermore, various genotypes of CETP gene have been associated with CETP levels and thus with atherosclerosis risk. Our aim was to study the association of CETP -629C/A gene polymorphism with CETP and HDL levels and their association if any with atherosclerosis. Study population consisted of angiographically documented 50 cases with coronary artery atherosclerosis and 50 controls negative for atherosclerosis of coronary artery. Serum lipid profile was measured on SYNCHRON CX-9 using standard kits. Serum CETP levels were measured by ELISA method. CETP -629C/A gene polymorphism was studied using PCR–RFLP method. There was no significant difference in lipid profile of the two groups. However, serum CETP level was significantly higher (46.44 ± 21.75 ng/ml) in cases than controls (37.10 ± 21.92 ng/ml) with p value =0.035. The frequency of -629A allele was higher (0.85) in cases than that of controls (0.81). Homozygosity of A allele was more in subjects with atherosclerosis of coronary artery. We conclude that CETP is atherogenic and could be used as atherogenic risk predictor in angiographically proven atherosclerosis. Also A allele of -629C/A polymorphism is more prevalent in cases; indicating its effect on expression of CETP gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Despres JP, Lemieux GR, Dagenais B, Cantin B, Lamarche B. HDL-C as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis. 2000;153:263–72.

    Article  CAS  PubMed  Google Scholar 

  2. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62:707–14.

    Article  CAS  PubMed  Google Scholar 

  3. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, et al. Gemfibrozil for the low levels of high density lipoprotein cholesterol. Veterans Affairs High Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med. 1999;341:410–8.

    Article  CAS  PubMed  Google Scholar 

  4. Manninen V, Elo MO, Frick MH, Happa K, Heinonen OP, Helo P, et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. J Am Med Assoc. 1988;260:641–51.

    Article  CAS  Google Scholar 

  5. Miller NE, Thelle DS, Forde OH, Mjos OD. The Tromso heart study: high density lipoprotein and coronary heart disease: a prospective case-control study. Lancet. 1977;1(8019):965–8.

    Article  CAS  PubMed  Google Scholar 

  6. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: Framingham Heart Study. Am J Med. 1977;62:707–14.

    Article  CAS  PubMed  Google Scholar 

  7. Assmann G, Schulte H, Oberwitter W, Hause WH. New aspects in the prediction of coronary artery disease: the Prospective Cardiovascular Munster Study. In: Fidge NH, Nestel PJ, editors. Atherosclerosis VII. Amsterdam: Elsevier; 1986. p. 19–24.

    Google Scholar 

  8. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res. 2005;96:1221–32.

    Article  CAS  PubMed  Google Scholar 

  9. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res. 1993;34:1255–74.

    CAS  PubMed  Google Scholar 

  10. Grooth GJ, Klerkx AH, Stroes ES, Staleenhoef AF, Kastelein JJ, Kuivenhoven JA. A review of CETP and its relation to atherosclerosis. J Lipid Res. 2004;45:1967–73.

    Article  PubMed  Google Scholar 

  11. Kovacic S, Bakran M. Genetic susceptibility to atherosclerosis. Stroke Res Treat. 2012;10:1–5.

    Article  Google Scholar 

  12. Agellon L, Quinet E, Gillette T, Drayana D, Brown M, Tall AR. Organization of the human cholesteryl ester transfer protein gene. Biochemistry. 1990;29:1372–6.

    Article  CAS  PubMed  Google Scholar 

  13. Daryana D, Lawn R. Multiple RFLPs at human cholesteryl ester transfer protein locus. Nucleic Acids Res. 1987;15:4698.

    Article  Google Scholar 

  14. Freeman D, Shepherd J, Packard CJ, Humphries SE, Gaffney D. An StuI RFLP at human cholesteryl ester transfer protein locus. Nucleic Acids Res. 1989;17:2880.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Zullani G, Hobbs HH. EcoNI polymorphism in the human cholesteryl ester transfer protein gene. Nucleic Acids Res. 1990;18:2834.

    Article  Google Scholar 

  16. Luis AJ, Zollman S, Sparkes S, Klisak I, Drayana D, Lawn RM, et al. Assignment of the human gene for cholesteryl ester transfer protein to chromosome 16q21–16q21. Genomics. 1987;1(3):232–5.

    Article  Google Scholar 

  17. Kondo I, Berg K, Daryana D, Lawn R. DNA polymorphism at locus for human cholesteryl ester transfer protein is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet. 1989;35(1):49–56.

    Article  CAS  PubMed  Google Scholar 

  18. Dachet C, Poirier O, Cambien F, Luc G, Chapman J, Rouis M. New functional promoter polymorphism, C-629A, in cholesteryl ester transfer protein gene related to CETP mass and HDL cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Atheroscler Thromb Vasc Biol. 2000;20:507–15.

    Article  CAS  Google Scholar 

  19. Borggereve SE, Hillege HL, de Jong PE, Zurrmann MW, Dullart RP, van Tol A, et al. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high density lipoprotein cholesterol: a population based study. JCEM. 2006;91(9):3382–8.

    Google Scholar 

  20. Samami KG, Noori M, Nobar MR, Chaleshtori MH, Farrokhi E, Amin MD. I405 V and -629C/A polymorphism of cholesteryl ester transfer protein in patients with coronary artery disease. Iran Biomed J. 2009;13(2):103–8.

    Google Scholar 

Download references

Funding

Study was part of thesis and was non-funded.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anita Devi.

Ethics declarations

Conflict of interest

None.

Ethical Compliance

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Devi, A., Singh, R., Dawar, R. et al. Association of Cholesteryl Ester Transfer Protein (CETP) Gene -629C/A Polymorphism with Angiographically Proven Atherosclerosis. Ind J Clin Biochem 32, 235–238 (2017). https://doi.org/10.1007/s12291-016-0585-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-016-0585-6

Keywords

Navigation